Gossypol

Gossypol is a lipid of Prenol Lipids (PR) class. Gossypol is associated with abnormalities such as Paralytic Ileus, PARKINSON DISEASE, LATE-ONSET, Fibrillation, Hepatic necrosis and Lymphopenia. The involved functions are known as Atrophic, Ulcer, Necrosis, Apoptosis and antagonists. Gossypol often locates in Mucous Membrane, Epithelium, Blood, Microsomes, Liver and Autophagic vacuole. The associated genes with Gossypol are BCL2A1 gene, BCL2 gene, Transgenes, IGH@ gene cluster and Bax protein (53-86). The related lipids are Promega, proteoliposomes, Phosphatidylserines and Liposomes. The related experimental models are Transgenic Model and Xenograft Model.

Cross Reference

Introduction

To understand associated biological information of Gossypol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Gossypol?

Gossypol is suspected in Severe Combined Immunodeficiency, Aortic Valve Insufficiency, PARKINSON DISEASE, LATE-ONSET, Infertility, CLEFT LIP, CONGENITAL HEALED, Pulmonary Fibrosis and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Gossypol

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Cattle Diseases D002418 24 associated lipids
Infertility, Male D007248 11 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Testicular Diseases D013733 15 associated lipids
Lymphoma, Large B-Cell, Diffuse D016403 13 associated lipids
Melanoma D008545 69 associated lipids
Weight Gain D015430 101 associated lipids
Abnormalities, Drug-Induced D000014 10 associated lipids
Glioma D005910 112 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Leukemia P388 D007941 43 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Endometriosis D004715 29 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Proteinuria D011507 30 associated lipids
Genital Neoplasms, Male D005834 3 associated lipids
Leukemia D007938 74 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Protein Deficiency D011488 5 associated lipids
Leukemia, Experimental D007942 42 associated lipids
Leukemia, Lymphocytic, Chronic, B-Cell D015451 25 associated lipids
Neoplasms, Hormone-Dependent D009376 23 associated lipids
Leiomyoma D007889 8 associated lipids
Nutrition Disorders D009748 6 associated lipids
Swine Diseases D013553 16 associated lipids
Pemphigoid, Bullous D010391 8 associated lipids
Infertility, Female D007247 5 associated lipids
Micronuclei, Chromosome-Defective D048629 33 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Acute Lung Injury D055371 33 associated lipids
Hematologic Neoplasms D019337 4 associated lipids
Darier Disease D007644 2 associated lipids
Endometrial Neoplasms D016889 30 associated lipids
Trypanosomiasis, African D014353 5 associated lipids
Retinoblastoma D012175 12 associated lipids
Lymphoma, B-Cell D016393 24 associated lipids
Carcinoma, Mucoepidermoid D018277 3 associated lipids
Lung Injury D055370 14 associated lipids
Retinal Neoplasms D019572 3 associated lipids
Prostatic Neoplasms, Castration-Resistant D064129 3 associated lipids
Leukemia, Biphenotypic, Acute D015456 2 associated lipids
Myxosarcoma D009236 1 associated lipids
Per page 10 20 50 100 | Total 52

PubChem Associated disorders and diseases

What pathways are associated with Gossypol

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Gossypol through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Gossypol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Gossypol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Gossypol?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Gossypol?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Gossypol?

Xenograft Model

Xenograft Model are used in the study 'Gossypol induces apoptosis by activating p53 in prostate cancer cells and prostate tumor-initiating cells.' (Volate SR et al., 2010), Xenograft Model are used in the study 'Sorafenib sensitizes (-)-gossypol-induced growth suppression in androgen-independent prostate cancer cells via Mcl-1 inhibition and Bak activation.' (Lian J et al., 2012), Xenograft Model are used in the study 'Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa.' (Meng Y et al., 2008), Xenograft Model are used in the study '(-)-Gossypol suppresses the growth of human prostate cancer xenografts via modulating VEGF signaling-mediated angiogenesis.' (Pang X et al., 2011) and Xenograft Model are used in the study 'Gossypol induces death receptor-5 through activation of the ROS-ERK-CHOP pathway and sensitizes colon cancer cells to TRAIL.' (Sung B et al., 2010).

Transgenic Model

Transgenic Model are used in the study 'Bcl-2 antagonist apogossypol (NSC736630) displays single-agent activity in Bcl-2-transgenic mice and has superior efficacy with less toxicity compared with gossypol (NSC19048).' (Kitada S et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Gossypol

Download all related citations
Per page 10 20 50 100 | Total 1511
Authors Title Published Journal PubMed Link
Semon B Dietary intake of cottonseed toxins is hypothesized to be a partial cause of Alzheimer's disorder. 2012 Med. Hypotheses pmid:22136946
Ilkevych NS et al. Vibrational spectra, structure and antioxidant activity of gossypol imine derivatives. 2012 Spectrochim Acta A Mol Biomol Spectrosc pmid:22078080
Özdoğan M et al. Effect of gossypol on blood serum parameters and small intestinal morphology of male broilers. 2012 J Anim Physiol Anim Nutr (Berl) pmid:21261752
Chien CC et al. The role of COX-2/PGE2 in gossypol-induced apoptosis of colorectal carcinoma cells. 2012 J. Cell. Physiol. pmid:22170686
Masood A et al. Downregulation of BCL2 by AT-101 enhances the antileukaemic effect of lenalidomide both by an immune dependant and independent manner. 2012 Br. J. Haematol. pmid:22171982
Lian J et al. Sorafenib sensitizes (-)-gossypol-induced growth suppression in androgen-independent prostate cancer cells via Mcl-1 inhibition and Bak activation. 2012 Mol. Cancer Ther. pmid:22188816
Li HQ et al. Structure-based design of rhodanine-based acylsulfonamide derivatives as antagonists of the anti-apoptotic Bcl-2 protein. 2012 Bioorg. Med. Chem. pmid:22739087
Ignatova M et al. Quaternized chitosan-coated nanofibrous materials containing gossypol: preparation by electrospinning, characterization and antiproliferative activity towards HeLa cells. 2012 Int J Pharm pmid:22728261
Sun P et al. Action of db-cAMP on the bystander effect and chemosensitivity through connexin 43 and Bcl-2-mediated pathways in medulloblastoma cells. 2012 Oncol. Rep. pmid:22766741
Hu W et al. Proapoptotic protein Smac mediates apoptosis in cisplatin-resistant ovarian cancer cells when treated with the anti-tumor agent AT101. 2012 J. Biol. Chem. pmid:22052903
Wang Y et al. Small molecule inhibition of the steroid receptor coactivators, SRC-3 and SRC-1. 2011 Mol. Endocrinol. pmid:22053001
Ready N et al. Double-blind, placebo-controlled, randomized phase 2 study of the proapoptotic agent AT-101 plus docetaxel, in second-line non-small cell lung cancer. 2011 J Thorac Oncol pmid:21289522
Zhou DR et al. [Gossypol decreases the expression of connexin 43 in Sertoli cells]. 2011 Zhonghua Nan Ke Xue pmid:22141269
Williams JL et al. Fitness cost of resistance to Bt cotton linked with increased gossypol content in pink bollworm larvae. 2011 PLoS ONE pmid:21738799
Chang Q et al. Drug synergistic antifertility effect of combined administration of low-dose gossypol with steroid hormones in rats. 2011 Chin. Med. J. pmid:21740776
Gunassekaran GR et al. In vitro and in vivo studies on antitumor effects of gossypol on human stomach adenocarcinoma (AGS) cell line and MNNG induced experimental gastric cancer. 2011 Biochem. Biophys. Res. Commun. pmid:21782799
Yin J et al. Novel O-glycosidic gossypol isomers and their bioactivities. 2011 Carbohydr. Res. pmid:21788013
Ouyang DY et al. Valproic acid synergistically enhances the cytotoxicity of gossypol in DU145 prostate cancer cells: an iTRTAQ-based quantitative proteomic analysis. 2011 J Proteomics pmid:21726675
Li H et al. Liposomes containing (-)-gossypol-enriched cottonseed oil suppress Bcl-2 and Bcl-xL expression in breast cancer cells. 2011 Pharm. Res. pmid:21710341
Dash R et al. Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24-mediated toxicity. 2011 Proc. Natl. Acad. Sci. U.S.A. pmid:21555592
Pang X et al. (-)-Gossypol suppresses the growth of human prostate cancer xenografts via modulating VEGF signaling-mediated angiogenesis. 2011 Mol. Cancer Ther. pmid:21372225
Guo Z et al. [Gossypol acetic acid induces DNA double-strand breaks in human mucoepidermoid carcinoma cell MEC-1]. 2011 Sheng Li Xue Bao pmid:21505732
Ma X et al. Environmental inhibitors of 11β-hydroxysteroid dehydrogenase type 2. 2011 Toxicology pmid:21515335
Mao YB et al. Cotton plants expressing CYP6AE14 double-stranded RNA show enhanced resistance to bollworms. 2011 Transgenic Res. pmid:20953975
Moon DO et al. Gossypol decreases tumor necrosis factor-α-induced intercellular adhesion molecule-1 expression via suppression of NF-κB activity. 2011 Food Chem. Toxicol. pmid:21223991
Mellon JE et al. Inhibitory effects of gossypol-related compounds on growth of Aspergillus flavus. 2011 Lett. Appl. Microbiol. pmid:21291481
Le TT et al. Evidence for a trianion intermediate in the metalation of 4-hydroxy-6,7-dimethoxy-8-methyl-2-naphthoic acid. Methodology and application to racemic 5,5'-didesisopropyl-5,5'-dialkylapogossypol derivatives. 2011 J. Org. Chem. pmid:21174400
Hu ZY et al. Apogossypolone targets mitochondria and light enhances its anticancer activity by stimulating generation of singlet oxygen and reactive oxygen species. 2011 Chin J Cancer pmid:21192843
Baggstrom MQ et al. A phase II study of AT-101 (Gossypol) in chemotherapy-sensitive recurrent extensive-stage small cell lung cancer. 2011 J Thorac Oncol pmid:21918390
Lu Z et al. Mirabamides E-H, HIV-inhibitory depsipeptides from the sponge Stelletta clavosa. 2011 J. Nat. Prod. pmid:21280591
Zhang P et al. Suppression of jasmonic acid-dependent defense in cotton plant by the mealybug Phenacoccus solenopsis. 2011 PLoS ONE pmid:21818315
Lian J et al. A natural BH3 mimetic induces autophagy in apoptosis-resistant prostate cancer via modulating Bcl-2-Beclin1 interaction at endoplasmic reticulum. 2011 Cell Death Differ. pmid:20577262
Spagnuolo C et al. Quercetin downregulates Mcl-1 by acting on mRNA stability and protein degradation. 2011 Br. J. Cancer pmid:21750559
Amm HM et al. Mechanisms of drug sensitization to TRA-8, an agonistic death receptor 5 antibody, involve modulation of the intrinsic apoptotic pathway in human breast cancer cells. 2011 Mol. Cancer Res. pmid:21357440
Granchi C et al. Discovery of N-hydroxyindole-based inhibitors of human lactate dehydrogenase isoform A (LDH-A) as starvation agents against cancer cells. 2011 J. Med. Chem. pmid:21332213
Celorio-Mancera Mde L et al. Transcriptional responses underlying the hormetic and detrimental effects of the plant secondary metabolite gossypol on the generalist herbivore Helicoverpa armigera. 2011 BMC Genomics pmid:22111916
Akagunduz O et al. Radiosensitization of hormone-refractory prostate cancer cells by gossypol treatment. 2010 Oct-Dec J BUON pmid:21229643
Tiliabaev KZ et al. [Synthesis, structures, and acute toxicity of gossypol nonsymmetrical aldehyde derivatives]. 2010 May-Jun Bioorg. Khim. pmid:20644599
Fulda S Modulation of apoptosis by natural products for cancer therapy. 2010 Planta Med. pmid:20486070
Blevins S et al. Effects of silymarin on gossypol toxicosis in divergent lines of chickens. 2010 Poult. Sci. pmid:20709972
Zhong S et al. Aromatase expression in leptin-pretreated human breast pre-adipocytes is enhanced by zeranol and suppressed by (-)-gossypol. 2010 Anticancer Res. pmid:21187493
Heist RS et al. Phase I/II study of AT-101 with topotecan in relapsed and refractory small cell lung cancer. 2010 J Thorac Oncol pmid:20808253
Ye W et al. Induction of apoptosis by (-)-gossypol-enriched cottonseed oil in human breast cancer cells. 2010 Int. J. Mol. Med. pmid:20514430
Sahin F et al. Gossypol exerts its cytotoxic effect on HL-60 leukemic cell line via decreasing activity of protein phosphatase 2A and interacting with human telomerase reverse transcriptase activity. 2010 Hematology pmid:20557672
D'Cruz SC et al. Effects of plants and plant products on the testis. 2010 Asian J. Androl. pmid:20562897
Gao P et al. The Bcl-2 homology domain 3 mimetic gossypol induces both Beclin 1-dependent and Beclin 1-independent cytoprotective autophagy in cancer cells. 2010 J. Biol. Chem. pmid:20529838
Volate SR et al. Gossypol induces apoptosis by activating p53 in prostate cancer cells and prostate tumor-initiating cells. 2010 Mol. Cancer Ther. pmid:20124455
Barelier S et al. Fragment-based deconstruction of Bcl-xL inhibitors. 2010 J. Med. Chem. pmid:20192224
Le A et al. Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. 2010 Proc. Natl. Acad. Sci. U.S.A. pmid:20133848
Wang H et al. Inhibition of calcineurin by quercetin in vitro and in Jurkat cells. 2010 J. Biochem. pmid:19880376